The future of CRISPR in cancer therapy looks promising, with ongoing advancements in the technology and a better understanding of its potential applications. Researchers are continually working to improve the precision and safety of CRISPR, and new delivery methods are being developed to target cancer cells more effectively. As more clinical trials are conducted, it is expected that CRISPR-based therapies will become more refined and widely available. Ultimately, CRISPR has the potential to revolutionize cancer treatment, offering new hope for patients with previously untreatable or hard-to-treat cancers.
